A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack. Most of the money from a newly-reached settlement over the fallout of the ...

If approved, Purdue Pharma will contribute $900 million upfront while the Sackler family pays $6.5 billion over the next 15 years – a $500 million increase from the previous settlement.

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis ...

The deal comes after the Supreme Court in June blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members — who themselves did not file for bankruptcy — from ...

Several states have reached a $7 billion settlement with Purdue Pharma based on the Sackler family's role in creating the opioid crisis, New York Attorney General Letitia James announced today.

By Jan Hoffman Seven months after the Supreme Court struck down a deal that would have resolved thousands of opioid cases against Purdue Pharma, the company’s owners, members of the Sackler ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

Purdue, under the leadership of the Sackler families, invented, manufactured and aggressively marketed opioid products for decades, according to the lawsuits. States and cities across the country ...

Purdue Pharma and its owners, the Sackler family, reached a settlement of up to $7.4 billion for its role in the opioid crisis, less than a year after the Supreme Court tossed out a proposed $6 ...